Skip to search formSkip to main contentSkip to account menu

Cozaar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Objective: This study examined the antifibrotic effect of Cozaar, an angiotensin II type 1 receptor antagonist, in an animal… 
2008
2008
Objective To study the effects of cozaar therapy on myocardial apoptosis and expressions of proapoptotic protein Bax and… 
2006
2006
OBJECTIVE:To investigate the efficacy of breviscapin injection in combination with cozaar for diabetic nephropathy.METHODS… 
2004
2004
Mean arterial blood pressure (MBP) was anabzed by spectral and chaotic anabses in hypertensive patients. Two antihypertensive… 
2001
2001
OBJECTIVE To compare the bioavailability of two potassic losartan immediate release tablet (50 mg) formulations (Losartan from… 
2001
2001
Objective: To investigate the antihypertensive effect of Cozaar and Its effects on reducing Left ventricular hypertrophy… 
2000
2000
To evaluate effectiveness of nonpeptide angiotensin-2 subtype-1 receptor antagonist losartan in therapy of symptomatic congestive… 
2000
2000
The chronopharmacodynamics of angiotension-converting enzyme (ACE) inhibitors, such as ramipril (R), enalapril (E), acetene (A… 
1997
1997
Losartan is the first angiotensin II (AII) antagonist available for clinical use. It has been designed specifically to antagonise… 
1995
1995
Background: Clinical experience with angiotensin converting enzyme (ACE) inhibitors has shown that inhibition of the renin…